Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: Analysis from Korea acute myocardial infarction registry

Cardiology Journal

Volumn 19, Issue 3, 2012, Pages 256-266

  Lee, Hye Won ^a   Hong, Taek Jong ^a   Yang, Mi Jin ^a   An, Sung Gyu ^a   Oh, Jun Hyok ^a   Choi, Jung Hyun ^a   Lee, Han Cheol ^a   Cha, Kwang Soo ^a   Hong, Ju Young ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Coronary artery disease; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INFARCT RELATED ARTERY REVASCULARIZATION; KOREA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVESSEL INFARCTION; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861987855     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: 10.5603/CJ.2012.0047     Document Type: Article

References (30)

1. Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction (TAMI) Study Group. Am Heart J, 1991; 121: 1042-1049.
2. Jaski BE, Cohen JD, Trausch J et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: Comparison of single-vessel versus multivessel coronary artery disease. Am Heart J, 1992; 124: 1427-1433.
3. Sorajja P, Gersh BJ, Cox DA et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J, 2007; 28: 1709-1716.
4. Parodi G, Memisha G, Valenti R et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: Results from a single centre experience. Heart, 2005; 91: 1541-1544.
5. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med, 2000; 343: 915-922.
6. Kushner FG, Hand M, Smith SC Jr. et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2009; 54: 2205-2241.
7. Shishehbor MH, Topol EJ, Mukherjee D et al.; TARGET Investigators. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol, 2006; 97: 1585-1590.
8. Ijsselmuiden AJ, Ezechiels J, Westendorp IC et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparison. Am Heart J, 2004; 148: 467-474.
9. Marenzi G, Assanelli E, Campodonico J et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med, 2009; 150: 170-177.
10. Toma M, Buller CE, Westerhout CM et al.; APEX-AMI Investigators. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: Insights from the APEX-AMI trial. Eur Heart J, 2010; 31: 1701-1707.
11. Politi L, Sgura F, Rossi R et al. Multivessel coronary disease in ST-elevation myocardial infarction: three different revascularization strategies and long-term outcomes. Heart, 2010; 96: 662-667.
12. Vlaar PJ, Mahmoud KD, Holmes DR Jr. et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol, 2011; 58: 692-703.
13. Kornowski R, Mehran R, Dangas G, et al.; HORIZONS-AMI Trial Investigators. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction. J Am Coll Cardiol, 2011; 58: 704-711.
14. Ambrose JA. In search of the "vulnerable plaque": Can it be localized and will focal regional therapy ever be an option for cardiac prevention? J Am Coll Cardiol, 2008; 51: 1539-1542.
15. Kukreja N, Onuma Y, Garcia-Garcia HM et al.; Interventional Cardioglogist of the Thorax-center(2000-2005). Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients. Am J Cardiol, 2009; 103: 203-211.
16. De Luca G, Suryapranata H, Stone GW et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA, 2005; 293: 1759-1765.
17. De Luca G, Suryapranata H, Stone GW et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials. Int J Cardiol, 2008; 126: 37-44.
18. De Luca G, Gibson CM, Bellandi F et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty(EGYPT) cooperation: An individual patient data meta-analysis. Heart, 2008; 94: 1548-1558.
19. Hanratty CG, Koyama Y, Rasmussen HH, Nelson GI, Hansen PS, Ward MR. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: Implications for immediate multivessel revascularization. J Am Coll Cardiol, 2002; 40: 911-916.
20. Tonino PA, De Bruyne B, Pijls NH et al.; FAME Study Investigators. Fractional flow reserve versus angioplasty for guiding percutaneous coronary intervention. N Engl J Med, 2009; 360: 213-224.
21. Roe MT, Cura FA, Joski PS et al. Initial experience with multivessel coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol, 2001; 88: 170-173.
22. Di Mario C, Mara S, Flavio A et al. Single vs. multivessel treatment during primary angioplasty: results of the multicentre randomized HEpacoat for culprit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) study. Int J Cardiovasc Int, 2004; 6: 128-133.
23. Chen LY, Lennon RJ, Grantham JA et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol, 2005; 95: 349-354.
24. Qarawani D, Nahir M, Abbound M, Hazanov Y, Hasin Y. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol, 2008; 123: 288-292.
25. Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J, 2008; 155: 140-146.
26. Kong JA, Chou ET, Minutello RM, Wong SC, Hong MK. Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: Report from the New York State Angioplasty Registry. Coron Artery Dis, 2006; 17: 71-75.
27. Navarese EP, De Servi S, Buffon A, Suryapranata H, De Luca G. Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with ST-elevation myocardial infarction and multivessel disease: A meta-analysis. J Thromb Thrombolysis, 2011; 31: 217-225.
28. Sethi A, Bahekar A, Bhuriya R, Singh S, Ahmed A, Khosla S. Complete versus culprit only revascularization in acute ST elevation myocardial infarction: A meta-analysis. Catheter Cardiovasc Interv, 2011; 77: 163-170.
29. Hannan EL, Samadashvili Z, Walford G et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. J Am Coll Cardiol Cardiovasc Interv, 2010; 3: 22-31.
30. Kim MC, Jeong MH, Ahn Y et al. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. Int J Cardiol, 2011; 153: 148-153.